Advertisement

Topics

Teva: FDA Approves QVAR RediHaler Inhalation Aerosol

08:25 EDT 7 Aug 2017 | FinanzNachrichten

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) said that the U.S. Food and Drug Administration or FDA has approved QVAR RediHaler (beclomethasone dipropionate HFA) inhalation a...

Original Article: Teva: FDA Approves QVAR RediHaler Inhalation Aerosol

NEXT ARTICLE

More From BioPortfolio on "Teva: FDA Approves QVAR RediHaler Inhalation Aerosol"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...